share_log

Oppenheimer Initiates Coverage On Xeris Biopharma Holdings With Outperform Rating, Announces Price Target of $5

Moomoo 24/7 ·  Mar 28 06:51

Oppenheimer analyst Leland Gershell initiates coverage on Xeris Biopharma Holdings (NASDAQ:XERS) with a Outperform rating and announces Price Target of $5.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment